| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 8.09 Billion |
| Market Size (2030) | USD 12.63 Billion |
| CAGR (2025 - 2030) | 9.32 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Flea and Tick Product Market Analysis
The Flea And Tick Product Market size is estimated at USD 8.09 billion in 2025, and is expected to reach USD 12.63 billion by 2030, at a CAGR of 9.32% during the forecast period (2025-2030).
The market is poised for rapid growth due to increasing pet ownership, concerns about zoonotic diseases, and the growing prevalence of flea and tick-borne illnesses.
The high burden of flea and tick diseases is expected to increase demand for treatment and is anticipated to contribute to the studied market’s growth during the forecast period. For instance, the Animal Health Institutes reported in November 2022 that they expected more flea and tick disease outbreaks in 2022. Thus, such an outbreak is expected to lead to increased flea and tick treatment demand, which is anticipated to contribute to the market’s growth over the projected period.
Public and private organizations promote understanding and prevention measures for animal zoonotic diseases globally. Several dedicated platforms and associations regularly spread awareness about pet animal health and preventing flea- and tick-transmitted diseases. For instance, in March 2024, PetIQ, Inc. launched NextStar, a 30-day topical protection, to mark the beginning of the flea and tick season. NextStar stands out as the fastest-acting solution, aiming to educate pet owners about the importance of year-round prevention. By staying proactive, pet parents can safeguard their furry companions from seasonal infestation spikes, ensuring both their pets and the cherished moments they share remain protected.
Furthermore, in February 2022, the United Kingdom Health Security Agency introduced a 'Be Tick Aware' to raise awareness about the country's potential dangers of ticks and tick-borne diseases. This tick awareness toolkit is designed to support the implementation of locally driven initiatives to inform the public about tick risks. It is available for use by local authorities and other interested parties to educate residents and visitors about tick dangers. The growing trend of pet adoption is predicted to drive the market for flea and tick products, as the expanding pet population and high prevalence of flea and tick-borne diseases are expected to contribute to the market's growth.
The product launches by the industry players are expected to increase access to these products, thereby boosting the market’s growth. For instance, in January 2022, Zoetis received FDA approval for Simparica Trio. This chewable tablet is the first and only combination product proven to avert infections that may result in Lyme disease.
Therefore, the market for flea and tick treatments is expected to grow during the analysis period. This growth is driven by an anticipated increase in flea and tick disease outbreaks, coupled with rising public awareness of these threats. However, potential barriers to market growth include the side effects associated with treatment and the availability of counterfeit pesticide products for pets.
Flea and Tick Product Market Trends
Dog Segment Expected to Witness Significant Growth During the Forecast Period
Dogs' soft, warm fur provides an inviting habitat for fleas and ticks. These parasites feed on the dogs' blood and can trigger health problems, from mild allergic reactions to serious tick-borne diseases. As these pests thrive more in warmer months, a range of products has been developed to combat them.
As the pet dog population grows, especially in developed nations, the demand for flea and tick control products increases. Companies are focusing on introducing new products that prevent the dig from fleas and ticks, thereby boosting the segment’s growth. For instance, in January 2024, Neogen Corporation introduced the Provecta Pro Flea & Tick Collar for Dogs, catering to canines 12 weeks and above. This collar, featuring Deltamethrin and (S)-Methoprene as its active ingredients, ensures a comprehensive shield against fleas, ticks, and mosquitoes for a notable six-month period. The collar boasts a flexible fit and a breakaway buckle crafted with a focus on pet comfort and safety.
Moreover, product launches play a pivotal role in driving the market’s growth. For instance, in July 2022, Pet Wellness Direct unveiled its latest flea shampoo, "Protect," designed to shield dogs from flea infestations. These product introductions diversify the range of innovative offerings and significantly propel the market's expansion.
As a result, the dog segment is anticipated to experience significant growth during the forecast period, fueled by the rising adoption of dogs and increased product launches.
Understand The Key Trends Shaping This Market
Download PDF
North America Expected to Hold Significant Market Share During the Forecast Period
North America is poised for substantial market growth, driven by rising adoption rates of companion animals, increasing disposable incomes, heightened per capita spending on animal healthcare, and a surge in product innovations.
Pet adoption has been on the rise in North America, and it is expected to boost the demand for flea and tick products for the well-being of pets. For instance, according to the Shelter Animal Counts 2023, 109,000 more dogs were adopted in 2023, and 34,000 more cats were adopted in 2023. Thus, growing adoption is expected to increase spending on healthcare and treatment as this animal is more susceptible to fleas and ticks, thereby boosting the demand for treatment during the forecast period.
Moreover, as pet ownership rises in the region, so does the uptake of pet insurance, a trend poised to further propel the growth of the flea and tick market. For instance, data published by the North American Pet Health Insurance Association (NAPHIA) in May 2024 showed that 6.25 million pets were insured in North America at the end of 2023, a 20.9% increase from the 5.17 million pets insured in 2022. Thus, a high number of pet insurance companies in the region are expected to increase the treatment adoption rate, thereby boosting the demand for the market during the forecast period.
Moreover, significant actions taken by regional market players are poised to further stimulate the market’s growth. For instance, in January 2023, Merck Animal Health secured approval from the United States Food and Drug Administration for its BRAVECTO Chews, specifically designed to treat Asian long-horned ticks in dogs.
Consequently, driven by rising pet adoption rates and substantial spending on animal healthcare, the North American region is projected to witness robust growth in the market studied.
Get Analysis on Important Geographic Markets
Download PDF
Flea and Tick Product Industry Overview
The flea and tick product market is semi-consolidated due to the presence of several companies operating globally and regionally. To stay competitive, the market players adopt several strategies, such as product launches, mergers and acquisitions, and partnerships. The key players operating in the market include Ceva, Elanco, Virbac, Boehringer Ingelheim, and Zoetis Inc.
Flea and Tick Product Market Leaders
-
Ceva
-
Elanco
-
Virbac
-
Boehringer Ingelheim
-
Zoetis Inc.
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Flea and Tick Product Market News
- January 2024: Merck Animal Health, also known as MSD Animal Health outside the United States and Canada, received approval from the European Commission (EC) for its BRAVECTO (fluralaner) 150 mg/ml powder and solvent for suspension for injection for dogs. This product is designed to swiftly eliminate fleas (Ctenocephalides felis and Ctenocephalides canis) and provide long-lasting tick protection. It effectively combats ticks, including Ixodes ricinus, Ixodes hexagonus, and Dermacentor reticulatus, for up to 12 months post-treatment and Rhipicephalus sanguineus for up to 12 months post a 4-day treatment.
- August 2023: Boehringer Ingelheim announced that the US Food and Drug Administration (FDA) approved a new label indication for NexGard (afoxolaner). This approval allows NexGard to be used in the treatment and control of Asian longhorned tick (Haemaphysalis longicornis) infestations in dogs and puppies. The treatment is effective for one month and is suitable for canines aged eight weeks and older, weighing at least four pounds.
Flea and Tick Product Industry Segmentation
As per the scope of this report, flea and tick products refer to various chemicals, drugs, and equipment that prevent the infestation of fleas and ticks in animals and cure the diseases caused by those parasites.
The flea and tick product market is segmented by product, animal, and geography. By product, the market is segmented as oral pill, spray, spot-on, powder, shampoo, collar, and other products. By animal, the market is segmented as dogs, cats, and other animals. By geography, the market is segmented as North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.
| By Product | Oral Pill | ||
| Spray | |||
| Spot On | |||
| Powder | |||
| Shampoo | |||
| Collar | |||
| Other Products | |||
| By Animal | Dog | ||
| Cat | |||
| Other Animals | |||
| By Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
Need A Different Region or Segment?
Customize Now
Flea and Tick Products Market Research FAQs
How big is the Flea And Tick Product Market?
The Flea And Tick Product Market size is expected to reach USD 8.09 billion in 2025 and grow at a CAGR of 9.32% to reach USD 12.63 billion by 2030.
What is the current Flea And Tick Product Market size?
In 2025, the Flea And Tick Product Market size is expected to reach USD 8.09 billion.
Who are the key players in Flea And Tick Product Market?
Ceva, Elanco, Virbac, Boehringer Ingelheim and Zoetis Inc. are the major companies operating in the Flea And Tick Product Market.
Which is the fastest growing region in Flea And Tick Product Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Flea And Tick Product Market?
In 2025, the North America accounts for the largest market share in Flea And Tick Product Market.
What years does this Flea And Tick Product Market cover, and what was the market size in 2024?
In 2024, the Flea And Tick Product Market size was estimated at USD 7.34 billion. The report covers the Flea And Tick Product Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Flea And Tick Product Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Flea and Tick Products Industry Report
Statistics for the 2025 Flea And Tick Product market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Flea And Tick Product analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
